Table 2.
Covariates of Studies Included in the Systematic Review and Meta‐analysis
| Study | hs‐CRP, mg/L, Mean±SD | SBP, mm Hg, Mean±SD | DBP, mm Hg, Mean±SD | Hemoglobin, g/dL, Mean±SD | HbA1c, %, Mean±SD | Albumin, g/L, Mean±SD | Creatinine, mg/dL, Mean±SD | TC, mg/dL, Mean±SD | LDL‐C, mg/dL, Mean±SD | Triglycerides, mg/dL, Mean±SD |
|---|---|---|---|---|---|---|---|---|---|---|
| Arsov et al, 201325 | 12.6±42.0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| de Vos et al, 201426 | N/A | 140.0±125.5 | 80±60.7 | N/A | 6.8±4.4 | N/A | N/A | N/A | N/A | N/A |
| Fraser et al, 201427 | N/A | 134. 0±18.0 | 72. 0±11.0 | 13.2±125.5 | N/A | N/A | N/A | N/A | N/A | N/A |
| Gerrits et al, 201228 | N/A | 146. 0±24.0 | 65. 0±20.0 | 12.6±1.3 | N/A | 38.0±5.0 | 9.9±2.7 | 146.9±34.8 | N/A | N/A |
| Kimura et al, 201429 | 1.4±1.7 | N/A | N/A | 10.1±1.6 | N/A | 37.0±0.4 | 10.4±3.4 | 148.3±N/A | 81.2±26.6 | 108.2±61.2 |
| Lutgers et al, 200930 | N/A | 146±±20.0 | 81±10.0 | N/A | 7.0±1.3 | N/A | 1.1±0.2 | 201.1±38.7 | 112.1±34.8 | 203.7±115.1 |
| Meerwaldt et al, 200531 | 4.8±5.6 | N/A | N/A | N/A | N/A | 38.3±2.6 | 11.1±2.7 | 204.9±N/A | 123.7±30.9 | 212.6±79.7 |
| Meerwaldt et al, 200732 | ||||||||||
| Type 2 DM patients | N/A | N/A | N/A | N/A | 8.2±0.9 | N/A | 1.0±0.2 | 196.1±N/A | 123.7±38.7 | 168.3±70.8 |
| Type 1 DM patients | N/A | N/A | N/A | N/A | 7.9±1.0 | N/A | 1.0±0.1 | 203.3±N/A | 123.7±27.1 | 146.1±70.8 |
| Nongnuch and Davenport, 201533 | 15.1±27.2 | N/A | N/A | 10.9±1.4 | 11.7±15.0 | 38.9±4.9 | N/A | 158.5±42.5 | N/A | N/A |
| Siriopol et al, 201534 | 4.3±36.5 | N/A | N/A | 11.3±1.6 | N/A | 47.6±64.0 | N/A | 185.0±275.6 | N/A | 160.0±449.1 |
DBP indicates diastolic blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin A1c; hs‐CRP, high‐sensitivity C‐reactive protein; LDL‐C, low‐density lipoprotein cholesterol; N/A, not available; SBP, systolic blood pressure; TC, total cholesterol.